PRESS RELEASE published on 04/27/2023 at 09:00, 1 year 6 months ago Good Start to 2023 Financial Year for GRAMMER AG
PRESS RELEASE published on 04/18/2023 at 10:05, 1 year 7 months ago EQS-Adhoc: GRAMMER Aktiengesellschaft: Revenue and earnings development in the first quarter of 2023 significantly above previous year's level
PRESS RELEASE published on 03/30/2023 at 09:00, 1 year 7 months ago GRAMMER AG increases revenue and operating earnings in 2022 and expresses optimism for financial year 2023
PRESS RELEASE published on 02/13/2023 at 14:57, 1 year 9 months ago GRAMMER AG achieves guidance for 2022 and anticipates significant earnings growth in fiscal year 2023
PRESS RELEASE published on 02/13/2023 at 14:55, 1 year 9 months ago EQS-Adhoc: GRAMMER AG recognizes impairment losses on property, plant and equipment and intangible assets and publishes guidance for fiscal year 2023
Published on 11/21/2024 at 13:30, 26 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 26 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 56 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 56 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 56 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 21 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 41 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 58 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 36 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 11 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 11 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
